Halberd Corporation | Press Releases, Latest News, Updates

May 28 2025

Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates

By Admin|2025-05-27T21:22:22-04:00May 28th, 2025|Investor News, News, Press Releases|0 Comments

Issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease. Jackson Center, PA, May 28, 2025 – Halberd Corporation (OTC "HALB”) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and pruritis in yet another case report and issues nationwide nephrologist solicitation ...

Mar 17 2025

Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects

By Admin|2025-03-16T21:52:55-04:00March 17th, 2025|Investor News, News, Press Releases|0 Comments

The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award! Jackson Center, PA, March 17, 2025 – Halberd Corporation (OTC "HALB”) partnered with Athena GTX on a profit-sharing agreement over a year ago. This enabled Halberd to utilize Athena’s expertise and experience in dealing with the federal government. Of the two technologies associated ...

Dec 2 2024

Halberd Update on WatchDawg® PTSD Treatment

By Admin|2024-12-01T19:39:01-05:00December 2nd, 2024|Featured, Investor News, News, Update Letter|0 Comments

Next Phase Pilot Study Jackson Center, PA December 2, 2024 – Halberd Corporation (OTC-PINK: "HALB”) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation. The results of that study can be found here. Based on the encouraging results of that initial pilot study, ...

Oct 1 2024

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

By Admin|2024-11-28T06:29:43-05:00October 1st, 2024|Featured, Investor News, Press Releases|0 Comments

Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System Jackson Center, PA October 1, 2024 – Halberd Corporation (OTC-PINK: "HALB”) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veteran participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 ...

Sep 11 2024

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD

By Admin|2024-09-10T19:05:30-04:00September 11th, 2024|Featured, Investor News, News, Press Releases|0 Comments

Breaking News: Development Just In! Contributing Funding and a Significant Additional Tool to Combat PTSD and TBI Jackson Center, PA September 11, 2024 – Halberd Corporation (OTC-PINK: "HALB”), in coordination with Athena Telemedicine Partners (ATP), and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with ...

Sep 9 2024

Halberd Corp. Issues Letter to Shareholders – Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction

By Admin|2024-09-08T17:19:55-04:00September 9th, 2024|Featured, Investor News, Press Releases|0 Comments

Early Pilot Study Data from Veteran Volunteers is Compelling. Part B. Jackson Center, PA September 5, 2024 – Halberd Corporation (OTC-PINK: "HALB”) We hope you have had an opportunity to check out this Press release’s Part A. This Part B supplements that release of a few days ago. As always reach out to us if ...

Sep 4 2024

Halberd Letter to Shareholders – Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction

By Admin|2024-09-03T18:06:24-04:00September 4th, 2024|Featured, Investor News, News, Press Releases, Update Letter|0 Comments

Early Pilot Study Data from Veteran Volunteers is Compelling. Jackson Center, PA September 4, 2024 – Halberd Corporation (OTC-PINK: "HALB”) To our shareholders. As promised, this is the second of three Press Releases on our recent progress. If you have not had a chance to review that last one, on the good news on our ...

Aug 26 2024

Halberd Corp. – Taking a Moment to Recenter Our Technical Progress

By Admin|2024-08-29T16:41:51-04:00August 26th, 2024|Investor News, Press Releases, Technology, Update Letter|0 Comments

Introducing Tri-axTM TBI Nasal Spray Treatment- the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal Jackson Center, PA August 26, 2024 – Halberd Corporation (OTC-PINK: "HALB”) This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing concern ...

Jul 24 2024

Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results

By Admin|2024-07-23T18:32:56-04:00July 24th, 2024|Featured, Investor News, Press Releases|0 Comments

Jackson Center, PA July 24, 2024 – Halberd Corporation (OTC-PINK: "HALB”) has announced encouraging preliminary outcomes from its Phase II testing at Mississippi State University (MSU) of its Tri-AxTM nasal spray, aimed at mitigating the effects of traumatic brain injury (TBI) following head trauma. Dr. Russell Carr, the project's Principal Investigator, commented, “In the early ...

May 22 2024

Halberd/Athena GTX Research Promises a Much Brighter Future

By Admin|2024-05-21T16:43:28-04:00May 22nd, 2024|Featured, Investor News, News, Press Releases, Technology|0 Comments

Walt Disney once said, “All our dreams can come true if we have the courage to pursue them”. Jackson Center, PA May 22, 2024 – Halberd Corporation (OTC-PINK: "HALB”) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues facing not only our military but people ...

12 Next

Halberd News

Press releases and updates on our medical breakthroughs.